Every other month DMRF Canada publishes Going Forward; our bi-monthly e-newsletter.
What's Making News
Toronto Western General Hospital is conducting a clinical research study to test a new drug for Cervical Dystonia (abnormal spasms in the neck).
The drug is currently approved for use in the USA and Canada for treating epilepsy. The purpose of this study is to test the safety and benefit in treating the symptoms of cervical dystonia.
All participants receive the active drug.
To participate you must:
Mike Stroh, friend of DMRF Canada and the Founder of Starts with Me, has published a Self Care and Self Awareness Guide:
Everyday practices to improve wellbeing, promote resilience, and nurture self compassion.
Click on the link below to download the Guide Today.
DMRF Canada is pleased to announce we are accepting applications for a two-year clinical and research fellowship to support the training of exceptionally qualified physicians in preparation for their clinical career in movement disorders with a focus on dystonia and a special competence in use of botulinum toxins.
September 24, 2018
DMRF Canada is thrilled to announce that through 2018 and 2019, they will be increasing research funding for dystonia research that focuses on better clinical treatments for dystonia with the addition of two new projects, specifically for researchers in Canada: